Ziprasidone

Suppliers

Names

[ CAS No. ]:
146939-27-7

[ Name ]:
Ziprasidone

[Synonym ]:
5-{2-4-(1,2-benzothiazol-3-yl)piperazin-1-ylethyl}-6-chloro-1,3-dihydro-2H-indol-2-one
5-{2-[4-(1,2-Benzisothiazol-3-yl)piperazin-1-yl]ethyl}-6-chloro-1,3-dihydro-2H-indol-2-one
ziprasidonum
Ziprasidone
UNII-6UKA5VEJ6X
5-{2-[4-(1,2-Benzothiazol-3-yl)piperazin-1-yl]ethyl}-6-chloro-1,3-dihydro-2H-indol-2-one
ziprasidona
EINECS 203-794-9
5-{2-[4-(1,2-Benzisothiazol-3-yl)piperazin-1-yl]ethyl}-6-chlor-1,3-dihydro-2H-indol-2-on
Zipwell
MFCD00866661
2H-Indol-2-one, 5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-
2H-indol-2-one, 5-2-4-(1,2-benzisothiazol-3-yl)-1-piperazinylethyl-6-chloro-1,3-dihydro-
5-{2-[4-(1,2-Benzothiazol-3-yl)-1-piperazinyl]ethyl}-6-chloro-1,3-dihydro-2H-indol-2-one
ziprazidone
Ziprasidone [INN:BAN]
Geodon
Zeldox
5-[2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl]-6-chloro-1,3-dihydroindol-2-one

Chemical & Physical Properties

[ Density]:
1.4±0.1 g/cm3

[ Boiling Point ]:
554.8±50.0 °C at 760 mmHg

[ Melting Point ]:
213-215°C

[ Molecular Formula ]:
C21H21ClN4OS

[ Molecular Weight ]:
412.94

[ Flash Point ]:
289.3±30.1 °C

[ PSA ]:
76.71000

[ LogP ]:
4.00

[ Vapour Pressure ]:
0.0±1.5 mmHg at 25°C

[ Index of Refraction ]:
1.681

[ Storage condition ]:
Refrigerator

MSDS

Safety Information

[ Symbol ]:

GHS02, GHS07, GHS08

[ Signal Word ]:
Danger

[ Hazard Statements ]:
H225-H315-H360FD

[ Supplemental HS ]:
May form explosive peroxides.

[ Precautionary Statements ]:
P201-P210-P308 + P313-P403 + P235

[ Hazard Codes ]:
C,N

[ Risk Phrases ]:
R22:Harmful if swallowed. R34:Causes burns. R50/53:Very Toxic to aquatic organisms, may cause long-term adverse effects in the aquatic environment . R20/21/22:Harmful by inhalation, in contact with skin and if swallowed .

[ Safety Phrases ]:
S26-S36/37/39-S45-S60-S61

[ RIDADR ]:
UN 3259 8/PG 3

[ WGK Germany ]:
2

[ RTECS ]:
JR6475000

[ Packaging Group ]:
II

[ Hazard Class ]:
8

[ HS Code ]:
29211980

Customs

[ HS Code ]: 29211980

Articles

Gingival pain: an unusual side effect of ziprasidone.

BMJ Case Rep. 2013 , doi:10.1136/bcr-2012-007577, (2013)

The patient is a 52-year-old man with schizophrenia who developed severe, unremitting gingival pain after his ziprasidone dosage was increased from 80 to 120 mg. His physical examination and laborator...

A thorough QTc study of 3 doses of iloperidone including metabolic inhibition via CYP2D6 and/or CYP3A4 and a comparison to quetiapine and ziprasidone.

J. Clin. Psychopharmacol. 33(1) , 3-10, (2013)

The potential for iloperidone, a D2/5-HT2A antipsychotic, to affect the heart rate-corrected QT interval (QTc) was assessed in the absence and presence of metabolic inhibitors in a randomized, open-la...

Association between second-generation antipsychotics and changes in body mass index in adolescents.

J. Adolesc. Health 52(3) , 336-43, (2013)

To assess the association of second-generation antipsychotics (SGAs) with changes in body mass index (BMI) among adolescents compared with a matched untreated comparison group.A retrospective cohort s...


More Articles


Related Compounds

  • Ziprasidone
  • Ziprasidone
  • Ziprasidone QT
  • Ziprasidone D8
  • Ziprasidone HCl
  • 3-Oxo Ziprasidone
  • 1,3-Dimethyl-8-[3-(2-oxopropoxy)phenyl]-1,3,5-trihydroimidazolidino[1,2-h]puri ne-2,4-dione
  • 1,3-Butanedione, 1-(2,5-dichlorophenyl)-
  • 1-(2,5-Difluorophenyl)butane-1,3-dione
  • N-[5-amino-2-(piperidin-1-yl)phenyl]acetamide
  • N-[5-amino-2-(morpholin-4-yl)phenyl]acetamide
  • N~2~-{2-[3-(Acetylamino)anilino]-2-oxoethyl}-2-furamide
  • N-(5-(piperidin-1-ylsulfonyl)thiazol-2-yl)acetamide
  • N-(5-((4-phenylpiperazin-1-yl)sulfonyl)thiazol-2-yl)acetamide
  • N-(5-(morpholinosulfonyl)thiazol-2-yl)acetamide
  • 2-((5-(4-bromophenyl)-1-(3-chlorophenyl)-1H-imidazol-2-yl)thio)-N-(5-methyl-1,3,4-thiadiazol-2-yl)acetamide
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.